Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 26

1.

Ibrutinib efficacy and tolerability in patients with relapsed chronic lymphocytic leukemia following allogeneic HCT.

Ryan CE, Sahaf B, Logan AC, O'Brien S, Byrd JC, Hillmen P, Brown JR, Dyer MJ, Mato AR, Keating MJ, Jaglowski S, Clow F, Rezvani AR, Styles L, Coutre SE, Miklos DB.

Blood. 2016 Dec 22;128(25):2899-2908. doi: 10.1182/blood-2016-06-715284. Epub 2016 Nov 1.

2.

High-throughput allogeneic antibody detection using protein microarrays.

Paul J, Sahaf B, Perloff S, Schoenrock K, Wu F, Nakasone H, Coller J, Miklos D.

J Immunol Methods. 2016 May;432:57-64. doi: 10.1016/j.jim.2016.02.009. Epub 2016 Feb 20.

3.

Characterization of immunoglobulin E plasma cells that are elevated in the upper airway mucosa of nonatopic patients with chronic rhinosinusitis without nasal polyps.

Rashan AR, Goshn E, Peterson A, Yang Y, Phillips M, Sahaf B, Herzenberg L, Nayak JV.

Int Forum Allergy Rhinol. 2016 Apr;6(4):378-84. doi: 10.1002/alr.21696. Epub 2016 Feb 16.

PMID:
26878990
4.

Presensitization to HY antigens in female donors prior to transplant is not associated with male recipient post-transplant HY antibody development nor with clinical outcomes.

Nakasone H, Sahaf B, Tian L, Wang T, Haagenson MD, Schoenrock K, Perloff S, Ryan CE, Wu F, Spellman SR, Lee SJ, Ritz J, Miklos DB; Center for International Blood and Marrow Transplantation.

Haematologica. 2016 Jan;101(1):e30-3. doi: 10.3324/haematol.2015.134551. Epub 2015 Oct 22. No abstract available.

5.

Risks and benefits of sex-mismatched hematopoietic cell transplantation differ according to conditioning strategy.

Nakasone H, Remberger M, Tian L, Brodin P, Sahaf B, Wu F, Mattsson J, Lowsky R, Negrin R, Miklos DB, Meyer E.

Haematologica. 2015 Nov;100(11):1477-85. doi: 10.3324/haematol.2015.125294. Epub 2015 Aug 6.

6.

Therapeutic benefits targeting B-cells in chronic graft-versus-host disease.

Nakasone H, Sahaf B, Miklos DB.

Int J Hematol. 2015 May;101(5):438-51. doi: 10.1007/s12185-015-1782-4. Epub 2015 Mar 27. Review.

PMID:
25812839
7.

Allogeneic HY antibodies detected 3 months after female-to-male HCT predict chronic GVHD and nonrelapse mortality in humans.

Nakasone H, Tian L, Sahaf B, Kawase T, Schoenrock K, Perloff S, Ryan CE, Paul J, Popli R, Wu F, Otani JM, Coller J, Warren EH 3rd, Miklos DB.

Blood. 2015 May 14;125(20):3193-201. doi: 10.1182/blood-2014-11-613323. Epub 2015 Mar 12.

8.

Linkage of inflammation and oxidative stress via release of glutathionylated peroxiredoxin-2, which acts as a danger signal.

Salzano S, Checconi P, Hanschmann EM, Lillig CH, Bowler LD, Chan P, Vaudry D, Mengozzi M, Coppo L, Sacre S, Atkuri KR, Sahaf B, Herzenberg LA, Herzenberg LA, Mullen L, Ghezzi P.

Proc Natl Acad Sci U S A. 2014 Aug 19;111(33):12157-62. doi: 10.1073/pnas.1401712111. Epub 2014 Aug 5.

9.

Clinical impact of H-Y alloimmunity.

Popli R, Sahaf B, Nakasone H, Lee JY, Miklos DB.

Immunol Res. 2014 May;58(2-3):249-58. doi: 10.1007/s12026-014-8514-3. Review.

10.

H-Y antigen-binding B cells develop in male recipients of female hematopoietic cells and associate with chronic graft vs. host disease.

Sahaf B, Yang Y, Arai S, Herzenberg LA, Herzenberg LA, Miklos DB.

Proc Natl Acad Sci U S A. 2013 Feb 19;110(8):3005-10. doi: 10.1073/pnas.1222900110. Epub 2013 Feb 4.

11.

Prophylactic rituximab after allogeneic transplantation decreases B-cell alloimmunity with low chronic GVHD incidence.

Arai S, Sahaf B, Narasimhan B, Chen GL, Jones CD, Lowsky R, Shizuru JA, Johnston LJ, Laport GG, Weng WK, Benjamin JE, Schaenman J, Brown J, Ramirez J, Zehnder JL, Negrin RS, Miklos DB.

Blood. 2012 Jun 21;119(25):6145-54. doi: 10.1182/blood-2011-12-395970. Epub 2012 May 4.

12.

High-throughput VDJ sequencing for quantification of minimal residual disease in chronic lymphocytic leukemia and immune reconstitution assessment.

Logan AC, Gao H, Wang C, Sahaf B, Jones CD, Marshall EL, Buño I, Armstrong R, Fire AZ, Weinberg KI, Mindrinos M, Zehnder JL, Boyd SD, Xiao W, Davis RW, Miklos DB.

Proc Natl Acad Sci U S A. 2011 Dec 27;108(52):21194-9. doi: 10.1073/pnas.1118357109. Epub 2011 Dec 12.

13.

Recombinant antigen microarrays for serum/plasma antibody detection.

Wadia PP, Sahaf B, Miklos DB.

Methods Mol Biol. 2011;723:81-104. doi: 10.1007/978-1-61779-043-0_7.

PMID:
21370061
14.

Individual variation in the germline Ig gene repertoire inferred from variable region gene rearrangements.

Boyd SD, Gaëta BA, Jackson KJ, Fire AZ, Marshall EL, Merker JD, Maniar JM, Zhang LN, Sahaf B, Jones CD, Simen BB, Hanczaruk B, Nguyen KD, Nadeau KC, Egholm M, Miklos DB, Zehnder JL, Collins AM.

J Immunol. 2010 Jun 15;184(12):6986-92. doi: 10.4049/jimmunol.1000445. Epub 2010 May 21.

15.

Measurement and clinical monitoring of human lymphocyte clonality by massively parallel VDJ pyrosequencing.

Boyd SD, Marshall EL, Merker JD, Maniar JM, Zhang LN, Sahaf B, Jones CD, Simen BB, Hanczaruk B, Nguyen KD, Nadeau KC, Egholm M, Miklos DB, Zehnder JL, Fire AZ.

Sci Transl Med. 2009 Dec 23;1(12):12ra23.

16.

Culturing of human peripheral blood cells reveals unsuspected lymphocyte responses relevant to HIV disease.

Sahaf B, Atkuri K, Heydari K, Malipatlolla M, Rappaport J, Regulier E, Herzenberg LA, Herzenberg LA.

Proc Natl Acad Sci U S A. 2008 Apr 1;105(13):5111-6. doi: 10.1073/pnas.0712363105. Epub 2008 Mar 25.

17.

Modern flow cytometry: a practical approach.

Tung JW, Heydari K, Tirouvanziam R, Sahaf B, Parks DR, Herzenberg LA, Herzenberg LA.

Clin Lab Med. 2007 Sep;27(3):453-68, v. Review.

18.

The extracellular microenvironment plays a key role in regulating the redox status of cell surface proteins in HIV-infected subjects.

Sahaf B, Heydari K, Herzenberg LA, Herzenberg LA.

Arch Biochem Biophys. 2005 Feb 1;434(1):26-32. Review.

PMID:
15629105
19.

Lymphocyte surface thiol levels.

Sahaf B, Heydari K, Herzenberg LA, Herzenberg LA.

Proc Natl Acad Sci U S A. 2003 Apr 1;100(7):4001-5. Epub 2003 Mar 17.

20.

The history and future of the fluorescence activated cell sorter and flow cytometry: a view from Stanford.

Herzenberg LA, Parks D, Sahaf B, Perez O, Roederer M, Herzenberg LA.

Clin Chem. 2002 Oct;48(10):1819-27.

21.

Enzyme-linked immunospot assay for detection of thioredoxin and thioredoxin reductase secretion from cells.

Sahaf B, Söderberg A, Ekerfelt C, Paulie S, Rosén A.

Methods Enzymol. 2002;353:22-35.

PMID:
12078496
22.

Secretion of 10-kDa and 12-kDa thioredoxin species from blood monocytes and transformed leukocytes.

Sahaf B, Rosén A.

Antioxid Redox Signal. 2000 Winter;2(4):717-26.

PMID:
11213477
23.

Thioredoxin blood level increases after severe burn injury.

Abdiu A, Nakamura H, Sahaf B, Yodoi J, Holmgren A, Rosén A.

Antioxid Redox Signal. 2000 Winter;2(4):707-16.

PMID:
11213476
24.
25.

Monoclonal antibodies to human thioredoxin reductase.

Söderberg A, Sahaf B, Holmgren A, Rosén A.

Biochem Biophys Res Commun. 1998 Aug 10;249(1):86-9.

PMID:
9705836
26.

Thioredoxin expression and localization in human cell lines: detection of full-length and truncated species.

Sahaf B, Söderberg A, Spyrou G, Barral AM, Pekkari K, Holmgren A, Rosén A.

Exp Cell Res. 1997 Oct 10;236(1):181-92.

PMID:
9344598

Supplemental Content

Support Center